Ermal Molla, MD
Rheumatology · Middletown, CTNPI 1902163975
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,217 and has fallen 60.9% since, to $475 in 2025.
Across 205 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$997
- AbbVie$737
- Lilly USA, LLC$363
- UCB, Inc.$289
- AstraZeneca$272
- Novartis$267
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,60499%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 40 | $997 |
| AbbVie | 33 | $737 |
| Lilly USA, LLC | 15 | $363 |
| UCB, Inc. | 11 | $289 |
| AstraZeneca(2 entities) | 12 | $272 |
| Novartis | 14 | $267 |
| Johnson & Johnson(2 entities) | 10 | $251 |
| GSK | 12 | $222 |
| Pfizer | 11 | $222 |
| Mallinckrodt Hospital Products Inc. | 7 | $154 |
| Sanofi | 4 | $117 |
| Aurinia Pharma U.S., Inc. | 5 | $116 |
| E.r. Squibb & Sons, L.L.C. | 5 | $106 |
| Boehringer Ingelheim | 3 | $99 |
| Bioventus LLC | 5 | $96 |
| Ultragenyx Pharmaceutical Inc. | 3 | $57 |
| Fresenius Kabi USA, LLC | 2 | $48 |
| Genentech USA, Inc. | 3 | $42 |
| Mallinckrodt Enterprises LLC | 2 | $41 |
| Sandoz | 2 | $39 |
| Radius Health, Inc. | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| Medexus Pharma, Inc. | 1 | $11 |
How this compares
$4,639 in reported general payments places this provider in the 70th percentile of 118 rheumatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 17 | $167,304 |
| Hydroxychloroquine Sulfate | 41 | $1,130 |
| MethotrexateMethotrexate Sodium | 33 | $466 |
| Allopurinol | 15 | $160 |
| Prednisone | 16 | $110 |
| Alendronate Sodium | 28 | $102 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Middletown
- Crispin AbarientosMiddletown$1K
- Kenneth MillerDanbury$873K
- Robert SchoenGuilford$638K
- Bret SohnStamford$447K
- Fotios KoumpourasNorth Haven$314K
- James SeiboldFarmington$300K
- Michael SpiegelDanbury$215K
- John MagaldiTorrington$157K
- Archana SharmaBristol$98K
- Richard RoseffDanbury$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.